VR Logo

Concord Drugs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: S Nagi Reddy

Managing Director: T Narsimha Reddy

Group: --

Listing: BSE: 538965

Headquarters: Hyderabad, Telangana

Website: www.concorddrugs.in

Key Facts

Market cap: R 13.99 Cr

Revenue (TTM): R 50.98 Cr

Earnings (TTM): R 0.43 Cr

Cash: R 0.18 Cr

Total Debt: R 9.83 Cr

Promoters' ownership: 42.78%

Liquidity: Low

52 Week range: R 12.35 - 23.50

Face value: R10.00

Shares outstanding: 78,61,750

Stock Performance

Time Period Concord Drugs S&P BSE Healthcare* S&P BSE Small Cap*
YTD18.675.068.37
1 month24.485.3110.92
3 months4.099.4712.43
1 Year-19.000.794.36
3 Years-30.92-1.864.71
5 Years---1.875.48
10 Years--11.245.53
As on 27-Jan-2020 *As on 24-Jan-2020
Year Concord Drugs S&P BSE Small Cap S&P BSE Healthcare
2019-33.63-6.85-3.55
2018-29.24-23.41-5.89
2017-34.6959.640.49
2016-19.211.77-12.88